nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—Doxorubicin—uterine cancer	0.657	0.859	CbGbCtD
Tetrabenazine—CYP2D6—Progesterone—uterine cancer	0.083	0.108	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—uterine cancer	0.0253	0.0331	CbGbCtD
Tetrabenazine—Parkinsonism—Medroxyprogesterone Acetate—uterine cancer	0.00507	0.0286	CcSEcCtD
Tetrabenazine—CBR1—myometrium—uterine cancer	0.005	0.092	CbGeAlD
Tetrabenazine—Menstruation irregular—Progesterone—uterine cancer	0.00459	0.0259	CcSEcCtD
Tetrabenazine—Balance disorder—Medroxyprogesterone Acetate—uterine cancer	0.00421	0.0238	CcSEcCtD
Tetrabenazine—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.00416	0.0235	CcSEcCtD
Tetrabenazine—CBR1—uterine cervix—uterine cancer	0.00389	0.0716	CbGeAlD
Tetrabenazine—CBR1—decidua—uterine cancer	0.00371	0.0682	CbGeAlD
Tetrabenazine—CBR1—renal system—uterine cancer	0.00364	0.067	CbGeAlD
Tetrabenazine—CBR1—endometrium—uterine cancer	0.00352	0.0647	CbGeAlD
Tetrabenazine—CBR1—mammalian vulva—uterine cancer	0.0034	0.0626	CbGeAlD
Tetrabenazine—SLC18A2—uterine cervix—uterine cancer	0.00334	0.0615	CbGeAlD
Tetrabenazine—CBR1—uterus—uterine cancer	0.00324	0.0597	CbGeAlD
Tetrabenazine—Memory impairment—Progesterone—uterine cancer	0.00324	0.0183	CcSEcCtD
Tetrabenazine—SLC18A2—endometrium—uterine cancer	0.00302	0.0557	CbGeAlD
Tetrabenazine—CBR1—female reproductive system—uterine cancer	0.00291	0.0536	CbGeAlD
Tetrabenazine—SLC18A2—uterus—uterine cancer	0.00279	0.0513	CbGeAlD
Tetrabenazine—Blood disorder—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.0156	CcSEcCtD
Tetrabenazine—Dysarthria—Progesterone—uterine cancer	0.00269	0.0152	CcSEcCtD
Tetrabenazine—CBR1—female gonad—uterine cancer	0.00265	0.0488	CbGeAlD
Tetrabenazine—CBR1—vagina—uterine cancer	0.00264	0.0485	CbGeAlD
Tetrabenazine—Gait disturbance—Progesterone—uterine cancer	0.0026	0.0147	CcSEcCtD
Tetrabenazine—SLC18A2—female reproductive system—uterine cancer	0.0025	0.0461	CbGeAlD
Tetrabenazine—Dysarthria—Medroxyprogesterone Acetate—uterine cancer	0.00243	0.0138	CcSEcCtD
Tetrabenazine—SLC18A2—vagina—uterine cancer	0.00227	0.0417	CbGeAlD
Tetrabenazine—Sleep disorder—Progesterone—uterine cancer	0.00213	0.012	CcSEcCtD
Tetrabenazine—Disorientation—Progesterone—uterine cancer	0.00206	0.0117	CcSEcCtD
Tetrabenazine—Osteoarthritis—Progesterone—uterine cancer	0.00184	0.0104	CcSEcCtD
Tetrabenazine—Irritability—Progesterone—uterine cancer	0.00176	0.00995	CcSEcCtD
Tetrabenazine—CBR1—lymph node—uterine cancer	0.0017	0.0314	CbGeAlD
Tetrabenazine—Osteoarthritis—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00945	CcSEcCtD
Tetrabenazine—Breast disorder—Progesterone—uterine cancer	0.00167	0.00942	CcSEcCtD
Tetrabenazine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00902	CcSEcCtD
Tetrabenazine—Dysphagia—Progesterone—uterine cancer	0.00159	0.00901	CcSEcCtD
Tetrabenazine—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00889	CcSEcCtD
Tetrabenazine—Bronchitis—Progesterone—uterine cancer	0.00153	0.00867	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00863	CcSEcCtD
Tetrabenazine—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00854	CcSEcCtD
Tetrabenazine—Dysuria—Progesterone—uterine cancer	0.00149	0.00843	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Progesterone—uterine cancer	0.00148	0.00838	CcSEcCtD
Tetrabenazine—SLC18A2—lymph node—uterine cancer	0.00147	0.027	CbGeAlD
Tetrabenazine—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00817	CcSEcCtD
Tetrabenazine—Drowsiness—Progesterone—uterine cancer	0.00142	0.00804	CcSEcCtD
Tetrabenazine—Depression—Progesterone—uterine cancer	0.00142	0.00801	CcSEcCtD
Tetrabenazine—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00785	CcSEcCtD
Tetrabenazine—Body temperature increased—Carboplatin—uterine cancer	0.00136	0.00771	CcSEcCtD
Tetrabenazine—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00764	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00759	CcSEcCtD
Tetrabenazine—Body temperature decreased—Epirubicin—uterine cancer	0.0013	0.00735	CcSEcCtD
Tetrabenazine—Hypothermia—Epirubicin—uterine cancer	0.0013	0.00735	CcSEcCtD
Tetrabenazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00728	CcSEcCtD
Tetrabenazine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00726	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Progesterone—uterine cancer	0.00126	0.00712	CcSEcCtD
Tetrabenazine—Urethral disorder—Progesterone—uterine cancer	0.00125	0.00707	CcSEcCtD
Tetrabenazine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00698	CcSEcCtD
Tetrabenazine—Body temperature decreased—Doxorubicin—uterine cancer	0.0012	0.0068	CcSEcCtD
Tetrabenazine—Hypothermia—Doxorubicin—uterine cancer	0.0012	0.0068	CcSEcCtD
Tetrabenazine—Eye disorder—Progesterone—uterine cancer	0.00119	0.00674	CcSEcCtD
Tetrabenazine—Cardiac disorder—Progesterone—uterine cancer	0.00118	0.0067	CcSEcCtD
Tetrabenazine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00666	CcSEcCtD
Tetrabenazine—Angiopathy—Progesterone—uterine cancer	0.00116	0.00655	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00646	CcSEcCtD
Tetrabenazine—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00641	CcSEcCtD
Tetrabenazine—Dysphagia—Dactinomycin—uterine cancer	0.00113	0.00637	CcSEcCtD
Tetrabenazine—Mental disorder—Progesterone—uterine cancer	0.00112	0.00632	CcSEcCtD
Tetrabenazine—Tension—Progesterone—uterine cancer	0.00109	0.00616	CcSEcCtD
Tetrabenazine—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00611	CcSEcCtD
Tetrabenazine—Nervousness—Progesterone—uterine cancer	0.00108	0.0061	CcSEcCtD
Tetrabenazine—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00607	CcSEcCtD
Tetrabenazine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00593	CcSEcCtD
Tetrabenazine—CYP2D6—renal system—uterine cancer	0.00104	0.0192	CbGeAlD
Tetrabenazine—Tremor—Progesterone—uterine cancer	0.00104	0.00588	CcSEcCtD
Tetrabenazine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00573	CcSEcCtD
Tetrabenazine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000988	0.00558	CcSEcCtD
Tetrabenazine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000978	0.00553	CcSEcCtD
Tetrabenazine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000943	0.00533	CcSEcCtD
Tetrabenazine—Anxiety—Progesterone—uterine cancer	0.000942	0.00533	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000939	0.00531	CcSEcCtD
Tetrabenazine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000925	0.00523	CcSEcCtD
Tetrabenazine—Dry mouth—Progesterone—uterine cancer	0.000925	0.00523	CcSEcCtD
Tetrabenazine—Confusional state—Progesterone—uterine cancer	0.000914	0.00517	CcSEcCtD
Tetrabenazine—Nervous system disorder—Progesterone—uterine cancer	0.000889	0.00503	CcSEcCtD
Tetrabenazine—Skin disorder—Progesterone—uterine cancer	0.000881	0.00498	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Progesterone—uterine cancer	0.000876	0.00495	CcSEcCtD
Tetrabenazine—Blood disorder—Epirubicin—uterine cancer	0.000872	0.00493	CcSEcCtD
Tetrabenazine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000854	0.00483	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000851	0.00481	CcSEcCtD
Tetrabenazine—Hypotension—Progesterone—uterine cancer	0.000847	0.00479	CcSEcCtD
Tetrabenazine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000838	0.00474	CcSEcCtD
Tetrabenazine—CYP2D6—female reproductive system—uterine cancer	0.000837	0.0154	CbGeAlD
Tetrabenazine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000828	0.00468	CcSEcCtD
Tetrabenazine—Insomnia—Progesterone—uterine cancer	0.00082	0.00464	CcSEcCtD
Tetrabenazine—Dysphagia—Etoposide—uterine cancer	0.000815	0.00461	CcSEcCtD
Tetrabenazine—Dyspnoea—Progesterone—uterine cancer	0.000808	0.00457	CcSEcCtD
Tetrabenazine—Blood disorder—Doxorubicin—uterine cancer	0.000807	0.00456	CcSEcCtD
Tetrabenazine—Somnolence—Progesterone—uterine cancer	0.000806	0.00456	CcSEcCtD
Tetrabenazine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000806	0.00455	CcSEcCtD
Tetrabenazine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000798	0.00451	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000794	0.00449	CcSEcCtD
Tetrabenazine—Decreased appetite—Progesterone—uterine cancer	0.000788	0.00446	CcSEcCtD
Tetrabenazine—Fatigue—Progesterone—uterine cancer	0.000782	0.00442	CcSEcCtD
Tetrabenazine—Constipation—Progesterone—uterine cancer	0.000775	0.00438	CcSEcCtD
Tetrabenazine—Dysarthria—Epirubicin—uterine cancer	0.00077	0.00436	CcSEcCtD
Tetrabenazine—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—uterine cancer	0.000768	0.239	CbGpPWpGaD
Tetrabenazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000768	0.00434	CcSEcCtD
Tetrabenazine—CYP2D6—female gonad—uterine cancer	0.000761	0.014	CbGeAlD
Tetrabenazine—Feeling abnormal—Progesterone—uterine cancer	0.000747	0.00422	CcSEcCtD
Tetrabenazine—Gait disturbance—Epirubicin—uterine cancer	0.000747	0.00422	CcSEcCtD
Tetrabenazine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000743	0.0042	CcSEcCtD
Tetrabenazine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000732	0.00414	CcSEcCtD
Tetrabenazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00073	0.00413	CcSEcCtD
Tetrabenazine—Body temperature increased—Progesterone—uterine cancer	0.000717	0.00405	CcSEcCtD
Tetrabenazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000714	0.00404	CcSEcCtD
Tetrabenazine—Dysarthria—Doxorubicin—uterine cancer	0.000713	0.00403	CcSEcCtD
Tetrabenazine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.004	CcSEcCtD
Tetrabenazine—Leukopenia—Dactinomycin—uterine cancer	0.000703	0.00397	CcSEcCtD
Tetrabenazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000702	0.00397	CcSEcCtD
Tetrabenazine—Gait disturbance—Doxorubicin—uterine cancer	0.000691	0.00391	CcSEcCtD
Tetrabenazine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.00383	CcSEcCtD
Tetrabenazine—Ecchymosis—Epirubicin—uterine cancer	0.000659	0.00372	CcSEcCtD
Tetrabenazine—Asthenia—Progesterone—uterine cancer	0.00065	0.00368	CcSEcCtD
Tetrabenazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000649	0.00367	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Etoposide—uterine cancer	0.000645	0.00364	CcSEcCtD
Tetrabenazine—Urethral disorder—Etoposide—uterine cancer	0.00064	0.00362	CcSEcCtD
Tetrabenazine—Diarrhoea—Progesterone—uterine cancer	0.00062	0.00351	CcSEcCtD
Tetrabenazine—Eye disorder—Etoposide—uterine cancer	0.00061	0.00345	CcSEcCtD
Tetrabenazine—Ecchymosis—Doxorubicin—uterine cancer	0.00061	0.00345	CcSEcCtD
Tetrabenazine—Cardiac disorder—Etoposide—uterine cancer	0.000606	0.00343	CcSEcCtD
Tetrabenazine—Dizziness—Progesterone—uterine cancer	0.000599	0.00339	CcSEcCtD
Tetrabenazine—Angiopathy—Etoposide—uterine cancer	0.000592	0.00335	CcSEcCtD
Tetrabenazine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000589	0.00333	CcSEcCtD
Tetrabenazine—Vomiting—Progesterone—uterine cancer	0.000576	0.00326	CcSEcCtD
Tetrabenazine—Headache—Progesterone—uterine cancer	0.000568	0.00321	CcSEcCtD
Tetrabenazine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000562	0.00318	CcSEcCtD
Tetrabenazine—Decreased appetite—Dactinomycin—uterine cancer	0.000557	0.00315	CcSEcCtD
Tetrabenazine—Fatigue—Dactinomycin—uterine cancer	0.000552	0.00312	CcSEcCtD
Tetrabenazine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000543	0.00307	CcSEcCtD
Tetrabenazine—Nausea—Progesterone—uterine cancer	0.000538	0.00304	CcSEcCtD
Tetrabenazine—Osteoarthritis—Epirubicin—uterine cancer	0.000529	0.00299	CcSEcCtD
Tetrabenazine—Feeling abnormal—Dactinomycin—uterine cancer	0.000528	0.00299	CcSEcCtD
Tetrabenazine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000522	0.00295	CcSEcCtD
Tetrabenazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000515	0.00291	CcSEcCtD
Tetrabenazine—Leukopenia—Etoposide—uterine cancer	0.000509	0.00288	CcSEcCtD
Tetrabenazine—Body temperature increased—Dactinomycin—uterine cancer	0.000507	0.00286	CcSEcCtD
Tetrabenazine—Ataxia—Epirubicin—uterine cancer	0.000497	0.00281	CcSEcCtD
Tetrabenazine—Osteoarthritis—Doxorubicin—uterine cancer	0.000489	0.00277	CcSEcCtD
Tetrabenazine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000488	0.00276	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000483	0.00273	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Epirubicin—uterine cancer	0.000483	0.00273	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00048	0.00272	CcSEcCtD
Tetrabenazine—Breast disorder—Epirubicin—uterine cancer	0.000478	0.0027	CcSEcCtD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—CDKN1C—uterine cancer	0.000476	0.148	CbGpPWpGaD
Tetrabenazine—Confusional state—Etoposide—uterine cancer	0.000468	0.00264	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—uterine cancer	0.00046	0.0026	CcSEcCtD
Tetrabenazine—Asthenia—Dactinomycin—uterine cancer	0.00046	0.0026	CcSEcCtD
Tetrabenazine—Dysphagia—Epirubicin—uterine cancer	0.000457	0.00258	CcSEcCtD
Tetrabenazine—Skin disorder—Etoposide—uterine cancer	0.00045	0.00255	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Etoposide—uterine cancer	0.000448	0.00253	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000447	0.00253	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000447	0.00253	CcSEcCtD
Tetrabenazine—Breast disorder—Doxorubicin—uterine cancer	0.000442	0.0025	CcSEcCtD
Tetrabenazine—Bronchitis—Epirubicin—uterine cancer	0.00044	0.00249	CcSEcCtD
Tetrabenazine—Diarrhoea—Dactinomycin—uterine cancer	0.000438	0.00248	CcSEcCtD
Tetrabenazine—Hypotension—Etoposide—uterine cancer	0.000433	0.00245	CcSEcCtD
Tetrabenazine—Dysuria—Epirubicin—uterine cancer	0.000427	0.00242	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000425	0.0024	CcSEcCtD
Tetrabenazine—Dysphagia—Doxorubicin—uterine cancer	0.000423	0.00239	CcSEcCtD
Tetrabenazine—Dyspnoea—Etoposide—uterine cancer	0.000413	0.00234	CcSEcCtD
Tetrabenazine—Somnolence—Etoposide—uterine cancer	0.000412	0.00233	CcSEcCtD
Tetrabenazine—Drowsiness—Epirubicin—uterine cancer	0.000408	0.0023	CcSEcCtD
Tetrabenazine—Vomiting—Dactinomycin—uterine cancer	0.000407	0.0023	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—uterine cancer	0.000407	0.0023	CcSEcCtD
Tetrabenazine—Decreased appetite—Etoposide—uterine cancer	0.000403	0.00228	CcSEcCtD
Tetrabenazine—Fatigue—Etoposide—uterine cancer	0.0004	0.00226	CcSEcCtD
Tetrabenazine—Constipation—Etoposide—uterine cancer	0.000397	0.00224	CcSEcCtD
Tetrabenazine—Dysuria—Doxorubicin—uterine cancer	0.000396	0.00224	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000393	0.00222	CcSEcCtD
Tetrabenazine—Sweating—Epirubicin—uterine cancer	0.000391	0.00221	CcSEcCtD
Tetrabenazine—Feeling abnormal—Etoposide—uterine cancer	0.000382	0.00216	CcSEcCtD
Tetrabenazine—Nausea—Dactinomycin—uterine cancer	0.000381	0.00215	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—uterine cancer	0.000377	0.00213	CcSEcCtD
Tetrabenazine—Bradycardia—Epirubicin—uterine cancer	0.000372	0.00211	CcSEcCtD
Tetrabenazine—Body temperature increased—Etoposide—uterine cancer	0.000367	0.00207	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—uterine cancer	0.000362	0.00204	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Epirubicin—uterine cancer	0.000361	0.00204	CcSEcCtD
Tetrabenazine—Urethral disorder—Epirubicin—uterine cancer	0.000359	0.00203	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—uterine cancer	0.000345	0.00195	CcSEcCtD
Tetrabenazine—Eye disorder—Epirubicin—uterine cancer	0.000342	0.00193	CcSEcCtD
Tetrabenazine—Cardiac disorder—Epirubicin—uterine cancer	0.00034	0.00192	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000334	0.00189	CcSEcCtD
Tetrabenazine—Asthenia—Etoposide—uterine cancer	0.000333	0.00188	CcSEcCtD
Tetrabenazine—Angiopathy—Epirubicin—uterine cancer	0.000332	0.00188	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—uterine cancer	0.000332	0.00188	CcSEcCtD
Tetrabenazine—Mental disorder—Epirubicin—uterine cancer	0.000321	0.00181	CcSEcCtD
Tetrabenazine—Diarrhoea—Etoposide—uterine cancer	0.000317	0.00179	CcSEcCtD
Tetrabenazine—Eye disorder—Doxorubicin—uterine cancer	0.000316	0.00179	CcSEcCtD
Tetrabenazine—Cardiac disorder—Doxorubicin—uterine cancer	0.000314	0.00178	CcSEcCtD
Tetrabenazine—Tension—Epirubicin—uterine cancer	0.000313	0.00177	CcSEcCtD
Tetrabenazine—Nervousness—Epirubicin—uterine cancer	0.000309	0.00175	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—uterine cancer	0.000307	0.00174	CcSEcCtD
Tetrabenazine—Dizziness—Etoposide—uterine cancer	0.000307	0.00173	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—uterine cancer	0.000297	0.00168	CcSEcCtD
Tetrabenazine—Vomiting—Etoposide—uterine cancer	0.000295	0.00167	CcSEcCtD
Tetrabenazine—Agitation—Epirubicin—uterine cancer	0.000293	0.00165	CcSEcCtD
Tetrabenazine—Headache—Etoposide—uterine cancer	0.000291	0.00164	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—uterine cancer	0.000289	0.00164	CcSEcCtD
Tetrabenazine—Nervousness—Doxorubicin—uterine cancer	0.000286	0.00162	CcSEcCtD
Tetrabenazine—Leukopenia—Epirubicin—uterine cancer	0.000285	0.00161	CcSEcCtD
Tetrabenazine—CBR1—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000277	0.0862	CbGpPWpGaD
Tetrabenazine—Nausea—Etoposide—uterine cancer	0.000275	0.00156	CcSEcCtD
Tetrabenazine—Agitation—Doxorubicin—uterine cancer	0.000271	0.00153	CcSEcCtD
Tetrabenazine—Anxiety—Epirubicin—uterine cancer	0.00027	0.00153	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000269	0.00152	CcSEcCtD
Tetrabenazine—Dry mouth—Epirubicin—uterine cancer	0.000265	0.0015	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—uterine cancer	0.000264	0.00149	CcSEcCtD
Tetrabenazine—Confusional state—Epirubicin—uterine cancer	0.000262	0.00148	CcSEcCtD
Tetrabenazine—Nervous system disorder—Epirubicin—uterine cancer	0.000255	0.00144	CcSEcCtD
Tetrabenazine—Skin disorder—Epirubicin—uterine cancer	0.000252	0.00143	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Epirubicin—uterine cancer	0.000251	0.00142	CcSEcCtD
Tetrabenazine—Anxiety—Doxorubicin—uterine cancer	0.00025	0.00141	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000249	0.00141	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—uterine cancer	0.000245	0.00139	CcSEcCtD
Tetrabenazine—Hypotension—Epirubicin—uterine cancer	0.000243	0.00137	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—uterine cancer	0.000243	0.00137	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—uterine cancer	0.000236	0.00133	CcSEcCtD
Tetrabenazine—Insomnia—Epirubicin—uterine cancer	0.000235	0.00133	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—uterine cancer	0.000234	0.00132	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000233	0.00131	CcSEcCtD
Tetrabenazine—Dyspnoea—Epirubicin—uterine cancer	0.000232	0.00131	CcSEcCtD
Tetrabenazine—Somnolence—Epirubicin—uterine cancer	0.000231	0.00131	CcSEcCtD
Tetrabenazine—Decreased appetite—Epirubicin—uterine cancer	0.000226	0.00128	CcSEcCtD
Tetrabenazine—Hypotension—Doxorubicin—uterine cancer	0.000225	0.00127	CcSEcCtD
Tetrabenazine—Fatigue—Epirubicin—uterine cancer	0.000224	0.00127	CcSEcCtD
Tetrabenazine—Constipation—Epirubicin—uterine cancer	0.000222	0.00126	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—uterine cancer	0.000218	0.00123	CcSEcCtD
Tetrabenazine—Dyspnoea—Doxorubicin—uterine cancer	0.000214	0.00121	CcSEcCtD
Tetrabenazine—Feeling abnormal—Epirubicin—uterine cancer	0.000214	0.00121	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—uterine cancer	0.000214	0.00121	CcSEcCtD
Tetrabenazine—Decreased appetite—Doxorubicin—uterine cancer	0.000209	0.00118	CcSEcCtD
Tetrabenazine—Fatigue—Doxorubicin—uterine cancer	0.000207	0.00117	CcSEcCtD
Tetrabenazine—Constipation—Doxorubicin—uterine cancer	0.000206	0.00116	CcSEcCtD
Tetrabenazine—Body temperature increased—Epirubicin—uterine cancer	0.000205	0.00116	CcSEcCtD
Tetrabenazine—Feeling abnormal—Doxorubicin—uterine cancer	0.000198	0.00112	CcSEcCtD
Tetrabenazine—Body temperature increased—Doxorubicin—uterine cancer	0.00019	0.00108	CcSEcCtD
Tetrabenazine—Asthenia—Epirubicin—uterine cancer	0.000187	0.00105	CcSEcCtD
Tetrabenazine—Diarrhoea—Epirubicin—uterine cancer	0.000178	0.00101	CcSEcCtD
Tetrabenazine—Asthenia—Doxorubicin—uterine cancer	0.000173	0.000976	CcSEcCtD
Tetrabenazine—Dizziness—Epirubicin—uterine cancer	0.000172	0.000972	CcSEcCtD
Tetrabenazine—Vomiting—Epirubicin—uterine cancer	0.000165	0.000934	CcSEcCtD
Tetrabenazine—Diarrhoea—Doxorubicin—uterine cancer	0.000165	0.00093	CcSEcCtD
Tetrabenazine—Headache—Epirubicin—uterine cancer	0.000163	0.000921	CcSEcCtD
Tetrabenazine—Dizziness—Doxorubicin—uterine cancer	0.000159	0.000899	CcSEcCtD
Tetrabenazine—Nausea—Epirubicin—uterine cancer	0.000154	0.000873	CcSEcCtD
Tetrabenazine—Vomiting—Doxorubicin—uterine cancer	0.000153	0.000865	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—uterine cancer	0.000151	0.000852	CcSEcCtD
Tetrabenazine—Nausea—Doxorubicin—uterine cancer	0.000143	0.000808	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—NFE2L2—uterine cancer	0.000141	0.0437	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GPX3—uterine cancer	0.000134	0.0417	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.71e-05	0.0301	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.02e-05	0.0218	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.02e-05	0.0218	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—ABCC9—uterine cancer	5.78e-05	0.0179	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.15e-05	0.016	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SRD5A2—uterine cancer	4.32e-05	0.0134	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—NDUFB11—uterine cancer	4.32e-05	0.0134	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.2e-05	0.013	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.97e-05	0.0123	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—STAR—uterine cancer	3.6e-05	0.0112	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	3.3e-05	0.0103	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	3.26e-05	0.0101	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKR1B1—uterine cancer	3.13e-05	0.00971	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—STAR—uterine cancer	3.13e-05	0.00971	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.11e-05	0.00965	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.09e-05	0.00959	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—HNF1B—uterine cancer	2.93e-05	0.0091	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	2.68e-05	0.00831	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	2.52e-05	0.00783	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—POLD1—uterine cancer	2.45e-05	0.00762	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	2.43e-05	0.00754	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	2.4e-05	0.00744	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	2.34e-05	0.00728	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKR1C1—uterine cancer	2.29e-05	0.00712	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—RRM2—uterine cancer	2.04e-05	0.00635	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—DCN—uterine cancer	1.98e-05	0.00616	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.97e-05	0.00612	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—EZH2—uterine cancer	1.88e-05	0.00584	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP11A1—uterine cancer	1.87e-05	0.00581	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKR1C3—uterine cancer	1.77e-05	0.00548	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	1.72e-05	0.00534	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	1.51e-05	0.00469	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	1.42e-05	0.00442	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	1.4e-05	0.00435	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP19A1—uterine cancer	1.38e-05	0.00427	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—STK11—uterine cancer	1.38e-05	0.00427	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	1.32e-05	0.00411	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.29e-05	0.00401	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.23e-05	0.00383	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	1.05e-05	0.00325	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—MTHFR—uterine cancer	1.03e-05	0.00321	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	1.03e-05	0.0032	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.11e-06	0.00283	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—HRAS—uterine cancer	9.06e-06	0.00281	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—HRAS—uterine cancer	6.94e-06	0.00216	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PTEN—uterine cancer	6.62e-06	0.00206	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	6.53e-06	0.00203	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CXCL8—uterine cancer	6.49e-06	0.00202	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—EP300—uterine cancer	6.31e-06	0.00196	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKR1B10—uterine cancer	6.26e-06	0.00195	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTEN—uterine cancer	5.75e-06	0.00179	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NDUFB11—uterine cancer	5.62e-06	0.00175	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SRD5A2—uterine cancer	5.62e-06	0.00175	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—EP300—uterine cancer	5.48e-06	0.0017	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RNF43—uterine cancer	5.19e-06	0.00161	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	5.16e-06	0.0016	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CCL2—uterine cancer	4.97e-06	0.00154	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INHBA—uterine cancer	4.75e-06	0.00147	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—uterine cancer	4.52e-06	0.0014	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKR1C1—uterine cancer	4.27e-06	0.00133	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—STAR—uterine cancer	4.06e-06	0.00126	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKR1B1—uterine cancer	4.06e-06	0.00126	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CA—uterine cancer	4.06e-06	0.00126	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CXCL8—uterine cancer	3.93e-06	0.00122	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKT1—uterine cancer	3.31e-06	0.00103	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKR1C3—uterine cancer	3.29e-06	0.00102	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PGR—uterine cancer	3.21e-06	0.000996	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—POLD1—uterine cancer	3.19e-06	0.00099	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—YWHAE—uterine cancer	3.06e-06	0.00095	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.98e-06	0.000926	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FBXW7—uterine cancer	2.93e-06	0.000911	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—RRM2—uterine cancer	2.66e-06	0.000826	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—DCN—uterine cancer	2.58e-06	0.000801	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STK11—uterine cancer	2.56e-06	0.000796	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCL2—uterine cancer	2.55e-06	0.000793	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.43e-06	0.000755	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SOCS3—uterine cancer	2.4e-06	0.000746	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN2B—uterine cancer	2.3e-06	0.000714	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.3e-06	0.000713	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1R—uterine cancer	2.23e-06	0.000693	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL8—uterine cancer	2.22e-06	0.00069	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SMAD3—uterine cancer	2.1e-06	0.000652	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL8—uterine cancer	2.02e-06	0.000627	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR2—uterine cancer	2e-06	0.000622	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.79e-06	0.000556	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—STK11—uterine cancer	1.79e-06	0.000556	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ESR1—uterine cancer	1.71e-06	0.000532	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—NRAS—uterine cancer	1.62e-06	0.000503	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCL2—uterine cancer	1.51e-06	0.000468	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CA—uterine cancer	1.41e-06	0.000438	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—uterine cancer	1.39e-06	0.000433	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—uterine cancer	1.34e-06	0.000417	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	1.28e-06	0.000398	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB2—uterine cancer	1.26e-06	0.00039	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL8—uterine cancer	1.19e-06	0.00037	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HRAS—uterine cancer	1.18e-06	0.000368	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	1.16e-06	0.000362	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	1.15e-06	0.000358	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	1.1e-06	0.000342	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTEN—uterine cancer	1.07e-06	0.000333	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT1—uterine cancer	1.05e-06	0.000325	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EP300—uterine cancer	1.02e-06	0.000317	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—uterine cancer	9.68e-07	0.000301	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NRAS—uterine cancer	9.56e-07	0.000297	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—uterine cancer	8.23e-07	0.000256	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	7.56e-07	0.000235	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTEN—uterine cancer	7.48e-07	0.000232	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—uterine cancer	7.31e-07	0.000227	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—EP300—uterine cancer	7.13e-07	0.000221	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HRAS—uterine cancer	7e-07	0.000217	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT1—uterine cancer	6.18e-07	0.000192	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CA—uterine cancer	5.27e-07	0.000164	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKT1—uterine cancer	4.31e-07	0.000134	CbGpPWpGaD
